Han Chen
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 10
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Co-authors
- Junwei Shi (1 shared paper)Xinping Xu (1 shared paper)Zhibing Lai (1 shared paper)Zhixiang Chen (1 shared paper)Yong Xiao (1 shared paper)Xiaoying Zhou (27 shared papers)Ye Yao (2 shared papers)Ning Wu (1 shared paper)
- Journals
- Medicine (5 papers)Journal of Cancer (4 papers)Aging (3 papers)Frontiers in Oncology (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Han Chen
188 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 157
- Cancer Research 675
- Hepatology 216
- Molecular Biology 1.7k
- Pathology and Forensic Medicine 284
- Health, Toxicology and Mutagenesis 203
Countries citing papers authored by Han Chen
This map shows the geographic impact of Han Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Chen more than expected).
Fields of papers citing papers by Han Chen
This network shows the impact of papers produced by Han Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Chen. The network helps show where Han Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Han Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 426 | |
| 2 | 2020 | 184 | |
| 3 | 2004 | 165 | |
| 4 | 2019 | 132 | |
| 5 | Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. | 2007 | 104 |
| 6 | 2019 | 102 | |
| 7 | 2015 | 98 | |
| 8 | 2018 | 92 | |
| 9 | 2022 | 86 | |
| 10 | 2004 | 86 | |
| 11 | 2013 | 85 | |
| 12 | 2015 | 84 | |
| 13 | 2011 | 70 | |
| 14 | 2011 | 66 | |
| 15 | 2021 | 62 | |
| 16 | 2016 | 62 | |
| 17 | 2018 | 59 | |
| 18 | 2015 | 53 | |
| 19 | Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells. | 2018 | 53 |
| 20 | 2016 | 52 |
About Han Chen
Han Chen is a scholar working on Cancer Research, Hepatology, Anesthesiology and Pain Medicine, Anatomy and Pulmonary and Respiratory Medicine, having authored 198 papers that have together received 3.9k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Esophageal Cancer Research and Treatment (12 papers), Cancer-related molecular mechanisms research (12 papers), Helicobacter pylori-related gastroenterology studies (10 papers), MicroRNA in disease regulation (10 papers), Gut microbiota and health (10 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (675 citations), Hepatology (216 citations), Molecular Biology (1.7k citations), Pathology and Forensic Medicine (284 citations) and Health, Toxicology and Mutagenesis (203 citations). Han Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Junwei Shi, Xinping Xu, Zhibing Lai, Zhixiang Chen, Yong Xiao, Xiaoying Zhou, Ye Yao, Ning Wu, Lijing L. Yan and Wenbo Wang. Their work appears in journals such as Medicine, Journal of Cancer, Aging, Frontiers in Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.